Loading...
NASDAQ: VTRS
Viatris Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
●S&P 500 since 2004
Market Cap
$15.46B
52w High
$16.47
52w Low
$6.85
P/E
-4.40
Volume
5.22M
Outstanding Shares
1.15B
Company profile
Viatris Inc. operates as a healthcare company worldwide.
CEOScott Andrew Smith
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees32,000
IPO dateMar 17, 1980
Valuation
Forward P/E—
EV/EBITDA-70.63
Enterprise value$27.93B
Stock splits
Oct 9, 20033:2
Jan 28, 20033:2
Aug 16, 19953:2
Aug 3, 19922:1
Aug 4, 19863:2
Feb 19, 19852:1
Aug 1, 19843:2
Mar 2, 19843:2
Profitability & growth
Revenue growth4.97%
Gross margin35.06%▼8.11%vs FY2024
Operating margin-18.62%▼27277.53%vs FY2024
ROE-23.89%▼602.06%vs FY2024
Analyst consensus
RatingHold
Target price$15.25▲13.64%
2
Buy
8
Hold
2
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 14, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.62
$0.56
Q3FY25
ActualEst.
$0.67
$0.62
Q4FY25
ActualEst.
$0.57
$0.53
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$3.58B
$3.47B
Q3FY25
ActualEst.
$3.76B
$3.62B
Q4FY25
ActualEst.
$3.7B
$3.53B
Q1FY26
Next Est.
—